Archiv der Kategorie ‘Celgene‘

Celgene (CELG) Upgrade from Hold to Buy – Analyst rating from Argus

Thursday, den 13. June 2013

2 More Good Reasons to Buy Celgene

Wednesday, den 12. June 2013

Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?

Monday, den 10. June 2013

Health Cares Best Stock: Celgene vs. Abbott Labs

Tuesday, den 9. April 2013

Final Four Stocks: Celgene vs. Johnson & Johnson

Monday, den 8. April 2013

Final Four Stocks: Celgene vs. Johnson & Johnson

Sunday, den 7. April 2013

Celgene (CELG) Upgrade from Hold to Buy – Analyst rating from Deutsche Bank

Friday, den 5. April 2013

Health Cares Sweet 16 Stocks: Celgene vs. Biogen

Monday, den 1. April 2013

2 Big Risks Threatening Celgene

Tuesday, den 26. March 2013

Celgene (CELG) Downgrade from Buy to Hold – Analyst rating from WallachBeth

Monday, den 25. March 2013

Celgene Trial Disappointment No Disaster

Tuesday, den 5. March 2013

The European Organisation for Rare Diseases (EURORDIS) Awards Celgene Corporation for Excellence in Medical Innovation in Rare Diseases

Wednesday, den 27. February 2013

Why Celgene Is Poised to Keep Popping

Saturday, den 16. February 2013

Celgenes CEO Talks New Approvals, Future Opportunities

Wednesday, den 13. February 2013

Celgene (CELG) Downgrade from Buy to Hold – Analyst rating from Argus

Monday, den 28. January 2013

Is Celgenes New Rally Sustainable?

Tuesday, den 15. January 2013

Celgene kaufen – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Wednesday, den 9. January 2013

Celgene kaufen – New Analyst Rating from RBC Capital Markets

Wednesday, den 9. January 2013

Celgene (CELG) Upgrade from Sector Perform to Outperform – Analyst rating from RBC Capital Mkts

Tuesday, den 8. January 2013

Celgene halten – New Analyst Rating from RBC Capital Markets

Monday, den 7. January 2013

Celgene halten – New Analyst Rating from RBC Capital Markets

Wednesday, den 2. January 2013

Celgene buy – New Analyst Rating from Jefferies & Company Inc.

Tuesday, den 13. November 2012

Celgene sector perform – New Analyst Rating from RBC Capital Markets

Tuesday, den 6. November 2012

Celgene neutral – New Analyst Rating from UBS AG

Friday, den 12. October 2012

Celgene neutral – New Analyst Rating from UBS AG

Tuesday, den 11. September 2012

Celgene neutral – New Analyst Rating from UBS AG

Monday, den 10. September 2012

Celgene outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Thursday, den 6. September 2012

Celgene (CELG) Upgrade from Hold to Buy – Analyst rating from Argus

Friday, den 29. June 2012

Celgene overweight – New Analyst Rating from Barclays Capital

Monday, den 25. June 2012

Celgene sector perform – New Analyst Rating from RBC Capital Markets

Monday, den 25. June 2012

Celgene buy – New Analyst Rating from Jefferies & Company Inc.

Monday, den 25. June 2012

Celgene sector perform – New Analyst Rating from RBC Capital Markets

Friday, den 22. June 2012

Celgene buy – New Analyst Rating from Citigroup Corp.

Friday, den 22. June 2012

Celgene overweight – New Analyst Rating from Barclays Capital

Tuesday, den 19. June 2012

Celgene (CELG) Downgrade from Outperform to Sector Perform – Analyst rating from RBC Capital Mkts

Monday, den 18. June 2012

Celgene ( CELG ) Initial Recommendation Buy – Analyst rating from Cantor Fitzgerald

Wednesday, den 4. April 2012

Celgene (CELG) Initial Recommendation – Buy – Analyst rating from Cantor Fitzgerald

Wednesday, den 4. April 2012

Celgene outperform – New Analyst Rating from RBC Capital Markets

Tuesday, den 20. March 2012

Celgene buy – New Analyst Rating from Stifel, Nicolaus & Co., Inc.

Friday, den 16. March 2012

Celgene outperform – New Analyst Rating from RBC Capital Markets

Friday, den 24. February 2012

Celgene kaufen – New Analyst Rating from Der Aktionaer

Thursday, den 9. February 2012

Celgene (CELG) Downgrade from Buy to Hold – Analyst rating from Argus

Friday, den 27. January 2012

Celgene ( CELG ) Downgrade from Buy to Hold – Analyst rating from Argus

Friday, den 27. January 2012

Celgene overweight – New Analyst Rating from Barclays Capital

Wednesday, den 11. January 2012

Celgene outperform – New Analyst Rating from Sanford C. Bernstein and Co., Inc.

Wednesday, den 4. January 2012